Your surgeon will clear you to resume medications once you've progressed from ice chips to liquids to soft foods without complications
10.1016/J.EURPOLYMJ.2024.113345 94 KhattakS.UllahI.SohailM.AkbarM
Integrative Potential and Clinical Insight From a functional medicine perspective, GLP-1, GLP-2, and VIP peptides could become adjunctive supports in MCAS and related conditions such as IBS, POTS, EhlersDanlos syndrome, chronic fatigue, and long COVID, where mast-celldriven neuroinflammation plays a central role
In China, public and clinical awareness of GLP-1 therapies for overweight and obesity had emerged prior to the approval of Wegovy and Mounjaro and was further strengthened following the drugs mid-2024 approvals for chronic weight management
At Elite Primary Care Group, our experienced providers will work closely with you to determine which medication may be best suited to your unique health needs and goals